CAP-6

N/A

Report date: 2023/03/13 17:21:58
NME

Base Information

Drug NameCAP-6
Drug Alias NameCAP-6
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionTubulin inhibitorsApoptosis stimulants
TargetsTubulin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAC BioScience SA
China Registration ClassN/A

Develop Information

Active CompaniesAC BioScience SA
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A